NRSN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Neurosense Therapeutics Ltd (NRSN) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The company's financial performance is weak, technical indicators are bearish, there are no positive trading signals, and no significant catalysts or trends to suggest a strong future performance. Given the lack of positive momentum and growth, it is better to avoid this stock at this time.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 48.997, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 0.926, with support at 0.835 and resistance at 1.017.
NULL identified. No recent news, no significant trading trends, and no positive signals from proprietary trading tools.
Technical indicators are bearish, and there is no recent news or trading activity to suggest positive momentum.
The company's financials for Q4 2024 are weak. Revenue remains at 0 with no growth, net income dropped by 100%, and EPS declined by 74.32% YoY. Gross margin remains at 0 with no improvement.
No data available for analyst ratings or price target changes.
